AU2003298215A1 - Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof - Google Patents

Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof

Info

Publication number
AU2003298215A1
AU2003298215A1 AU2003298215A AU2003298215A AU2003298215A1 AU 2003298215 A1 AU2003298215 A1 AU 2003298215A1 AU 2003298215 A AU2003298215 A AU 2003298215A AU 2003298215 A AU2003298215 A AU 2003298215A AU 2003298215 A1 AU2003298215 A1 AU 2003298215A1
Authority
AU
Australia
Prior art keywords
electroshock
utilization
obtaining
biologically active
blood serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298215A
Inventor
Christoph Hanz
Vitali Alexandrovich Shestakov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Owen Holding Ltd
Original Assignee
Owen Holding Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Owen Holding Ltd filed Critical Owen Holding Ltd
Publication of AU2003298215A1 publication Critical patent/AU2003298215A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003298215A 2003-12-18 2003-12-18 Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof Abandoned AU2003298215A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2003/014578 WO2005058333A1 (en) 2003-12-18 2003-12-18 Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof

Publications (1)

Publication Number Publication Date
AU2003298215A1 true AU2003298215A1 (en) 2005-07-05

Family

ID=34684505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298215A Abandoned AU2003298215A1 (en) 2003-12-18 2003-12-18 Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof

Country Status (3)

Country Link
CN (1) CN1893961B (en)
AU (1) AU2003298215A1 (en)
WO (1) WO2005058333A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797890A1 (en) * 2005-12-09 2007-06-20 OWEN Holding LTD A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof
CN108348624B (en) * 2015-08-04 2021-07-27 瓦克星治疗有限责任公司 Ionizing radiation sterilization of biopharmaceuticals based on bacterial minicells and methods of use
CN115261321B (en) * 2022-09-27 2022-12-27 北京大学口腔医学院 Method for enhancing anti-tumor function of T lymphocyte and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064228A1 (en) * 2000-02-29 2001-09-07 Owen Holding Ltd Method for producing a bioactive substance from blood serum

Also Published As

Publication number Publication date
CN1893961B (en) 2010-09-22
WO2005058333A1 (en) 2005-06-30
CN1893961A (en) 2007-01-10

Similar Documents

Publication Publication Date Title
AU2003268200A1 (en) Bioreactors with substance injection capacity
AU2003254042A1 (en) Infusion pump and method for use
AU2003266700A1 (en) Porous article and method for production thereof and electrochemical element using the porous article
AU2002314790A1 (en) Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
IL172930A (en) Antiballistic materials and process
AU2003257179A1 (en) Drug-loaded biological material chemically treated with genipin
AU2003269751A1 (en) Immobilization method
IL172945A0 (en) Thin, stratified, reinforced slab and method for the manufacture thereof
EP1577384A4 (en) Plant with reduced protein content in seed, method of constructing the same and method of using the same
AU2003297870A1 (en) Reinforced fabric substrate and method for making the same
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2001256373A1 (en) Syringe and method for the use thereof
AU2002368286A1 (en) Cellular structure with internal limiting member and method for making the cellular structure
EP1679089A4 (en) Biological member and method for manufacturing thereof
AU2003262238A1 (en) Incubator and culture device
GB2405641B (en) Automated biological growth and dispensing system
AU2003301300A1 (en) Disposable/recylable pallet system and method
AU2003298215A1 (en) Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof
AU2003227171A1 (en) A microbe preparation for treating waste alcohol, its preparation method and the fermentation process
AU2003286930A1 (en) Hydroconversion catalyst and method for making the catalyst
AU2003202168A1 (en) Processes for improving binding capability and biological digestability
AU2003280615A1 (en) Transplantation material for regenerating biological tissue and process for producing the same
AU2003289861A1 (en) Method for producing ferromagnetic material, said material and its use
AU2003269506A1 (en) United-type receiving case contained wet tissue and general tissue at the same time and the manufacturing method
AU2003261904A1 (en) Water-absorbing resin and method for manufacturing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase